These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 17201625)
21. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder. Lurie S; O'Quinn A J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171 [TBL] [Abstract][Full Text] [Related]
22. Pregnancy and delivery complications and treatment approach in attention deficit hyperactivity disorder. Aktepe E; Ozkorumak E; Tanriöver-Kandil S Turk J Pediatr; 2009; 51(5):478-84. PubMed ID: 20112604 [TBL] [Abstract][Full Text] [Related]
23. Trichotillomania in Attention-Deficit/Hyperactivity Disorder Under Methylphenidate Treatment. Kara T; Akaltun İ J Clin Psychopharmacol; 2017 Aug; 37(4):484. PubMed ID: 28492426 [No Abstract] [Full Text] [Related]
24. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult. Greydanus DE; Pratt HD; Patel DR Dis Mon; 2007 Feb; 53(2):70-131. PubMed ID: 17386306 [TBL] [Abstract][Full Text] [Related]
25. ADHD, methylphenidate and driving: does some legislation endanger public health? Verster JC; Cox DJ J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623 [No Abstract] [Full Text] [Related]
26. Naturalistic long-term use of methylphenidate in bipolar disorder. Lydon E; El-Mallakh RS J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196 [TBL] [Abstract][Full Text] [Related]
27. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007. Janols LO; Liliemark J; Klintberg K; von Knorring AL Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258 [TBL] [Abstract][Full Text] [Related]
28. Methylphenidate an effective treatment for ADHD? McDougle CJ J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613 [No Abstract] [Full Text] [Related]
29. Cotempla XR-ODT--another long-acting methylphenidate for ADHD. Med Lett Drugs Ther; 2017 Nov; 59(1533):183-185. PubMed ID: 29125594 [No Abstract] [Full Text] [Related]
31. ADHD and insomnia. Cortese S; Lecendreux M; Mouren MC; Konofal E J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):384-5. PubMed ID: 16601641 [No Abstract] [Full Text] [Related]
32. [Attention deficit disorder with hyperactivity in children: diagnosis and therapeutic management]. Vallée L Arch Pediatr; 2000 Oct; 7(10):1111-6. PubMed ID: 11075268 [TBL] [Abstract][Full Text] [Related]
33. [Methylphenidate. A drug for attention deficit disorders to be used with precaution]. Taéron C Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855 [No Abstract] [Full Text] [Related]
35. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)]. Golubchik P; Sever J; Weizman A Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124 [TBL] [Abstract][Full Text] [Related]
36. Drugs and children. Pinkham JR ASDC J Dent Child; 2002; 69(1):10. PubMed ID: 12119805 [No Abstract] [Full Text] [Related]
37. [Basics of the drug therapy for attention deficit hyperactivity disorders in adolescents]. Airaksinen E; Airaksinen MM Duodecim; 2003; 119(16):1553-62. PubMed ID: 14535028 [No Abstract] [Full Text] [Related]
38. Focalin XR for ADHD. Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368 [No Abstract] [Full Text] [Related]